Decoding DLBCL: How AID and TET2 Cooperation Could Revolutionize Lymphoma Treatment
Unlocking the secrets of DLBCL, scientists have discovered a powerful partnership between AID and TET2 that controls cancer-promoting gene expression. This breakthrough could lead to innovative, targeted treatments for this aggressive lymphoma.